Jazz Pharmaceuticals Plc Revenue per Employee (JAZZ), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Jazz Pharmaceuticals Plc  (NASDAQ: JAZZ)
 

Jazz Pharmaceuticals Plc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 10.38% in the third quarter 2026, year on year to cumulative value of $4,718 million, Jazz Pharmaceuticals Plc's revenue per employee grew on a trailing twelve months basis to $ 1,632,570, this is below the company average.
Within the Healthcare sector Employees of 48 other companies have achieved higher revenue per employee. While Jazz Pharmaceuticals Plc's total ranking has deteriorated compared to the previous quarter from 431 to 575. Jazz Pharmaceuticals Plc has 2,890 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

JAZZ Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 10.38 % 15.55 % 19.05 % 10.09 % 6.74 %
Sales per Employee (TTM) $ 1,632,570 1,592,122 1,535,863 1,476,673 1,438,697
JAZZ's Total Ranking # 575 # 431 # 440 # 488 #
Seq. Revenue Change 2.87 % 13.04 % -10.77 % 6.38 % 7.69 %

JAZZ Company Profile >> Back to JAZZ Efficiency Comparisons >> Compare JAZZ Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 33
Healthcare Sector # 49
Overall Market # 575

Revenue per Employee Statistics
High Average Low
$ 1,592,122 $ 777,317 $ 94,213
(Jun 30 2026)   (Dec 31 2011)



Financial Statements
Jazz Pharmaceuticals Plc's Revenue MRQ $ 1,243 Millions Visit JAZZ's Income Statement
Jazz Pharmaceuticals Plc's Revenues TTM $ 4,718 Millions Visit JAZZ's aggregate revenue growth
What are JAZZ's Sales? Visit JAZZ's Sales by Segment




Other Ratios
Jazz Pharmaceuticals Plc's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
JAZZ's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for JAZZ's Competitors
Revenue per Employee for JAZZ's Suppliers
Revenue per Employee for JAZZ's Customers

You may also want to know
JAZZ's Sales Growth Rates JAZZ's Pe Price to earnings ratio JAZZ's Receivables Turnover Ratio JAZZ's Stock Quote
JAZZ's Net Income Growth Rates JAZZ's Ps Price to Sales ratio JAZZ's Sales per Employee JAZZ's Asset Turnover Ratio
JAZZ's Net Margin JAZZ's Pb Price to Book ratio JAZZ's Financial Strength Ratios JAZZ's Dividend Payout Ratio
Date modified: 2026-11-03T06:25:36+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Kiniksa Pharmaceuticals International Plc  2,584,598.36 $ 945.963  Million 366 
Aurinia Pharmaceuticals Inc   2,513,578.12 $ 321.738  Million 128 
Nurix Therapeutics Inc   2,214,309.15 $ 701.936  Million 317 
Exelixis Inc   2,176,862.25 $ 2,496.861  Million 1,147 
Incyte Corporation  2,113,485.94 $ 6,010.754  Million 2,844 
Alnylam Pharmaceuticals Inc   2,005,296.80 $ 5,013.242  Million 2,500 
Gilead Sciences Inc   1,822,823.53 $ 30,988.000  Million 17,000 
Eli Lilly And Company  1,729,240.00 $ 86,462.000  Million 50,000 
Bristol myers Squibb Company  1,539,476.92 $ 50,033.000  Million 32,500 
Indivior Pharmaceuticals Inc   1,376,000.00 $ 1,376.000  Million 1,000 
Biogen Inc   1,372,973.33 $ 10,297.300  Million 7,500 
Supernus Pharmaceuticals inc   1,326,849.69 $ 865.106  Million 652 
Ptc Therapeutics inc   1,166,048.44 $ 1,155.554  Million 991 
Bridgebio Pharma Inc   1,126,984.51 $ 945.540  Million 839 
Regeneron Pharmaceuticals Inc   1,096,443.87 $ 16,896.200  Million 15,410 
Alphatec Holdings Inc   919,662.65 $ 839.652  Million 913 
Insmed Inc  888,846.15 $ 1,479.040  Million 1,664 
Carlisle Companies Incorporated  883,644.07 $ 5,213.500  Million 5,900 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.